Veeva Basics Revolutionizes Operations for Over 100 Emerging Biotechs
Veeva Basics Revolutionizes Operations for Over 100 Emerging Biotechs
In today's fast-evolving biotech landscape, companies are continuously seeking innovative solutions to streamline their operations. In this regard, Veeva Systems has made a significant mark by revealing that more than 100 emerging biotechs are now harnessing the capabilities of Veeva Basics. This versatile platform simplifies and standardizes operations across clinical, regulatory, and quality domains, providing essential support for growth in an increasingly competitive market.
Meeting the Needs of Growing Biotechs
With the emergence of new technologies and methodologies, biotechs require robust solutions that not only address current needs but can also scale as their operations expand. Veeva Basics offers an industry-leading, simple solution powered by pre-configured and pre-validated applications designed for fast deployment. Built on the Vault Platform, the transition to a full Vault solution can be accomplished seamlessly, eliminating the need for complex migrations.
According to Veeva's general manager for Basics, Steve Harper, the platform's impact on emerging biotechs has been profound. "This innovative approach allows biotech leaders to connect, learn, and lay down a solid foundation for growth during events such as the Veeva RD and Quality Summit held in Boston, where more than 100 biotech leaders from 60 different organizations convened to discuss and shape the future of operations," he said.
New Additions to Veeva Basics
To further enhance its offerings, Veeva is introducing two new applications to Veeva Basics aimed at addressing critical quality control and commercial needs.
- - Veeva LIMS Basics: Tailored for virtual companies, this application facilitates contract manufacturing organization (CMO) oversight, including batch release processes and certificate of analysis (CoA) capabilities. A stability functionality is also expected to roll out in 2026, providing even more robust support.
- - Veeva PromoMats Basics: This comprehensive solution addresses the full content lifecycle management process. It encompasses crucial activities such as approval, storage, distribution of promotional content, and managing claims efficiently.
Set to be available in early 2026, these applications follow the proven efficacy standards of the Vault Platform, allowing clients to expand their technological infrastructure as they evolve. For more detailed information on Veeva Basics, industry professionals are encouraged to visit the dedicated website at veevabasics.com.
Industry Voices on Veeva Basics
Leaders from various biotech companies have shared their experiences with Veeva Basics, emphasizing its critical role in scaling their operations effectively. Richard Tornai, Senior Director of IT and RD Clinical at Structure Therapeutics, remarked, "As a rapidly growing company, we recognized the importance of standardizing our processes using Veeva Basics, which adheres to industry best practices. The agility of this solution not only meets our current needs but also ensures access to the Veeva Vault Platform as we continue to grow."
Another voice from Whitehawk Therapeutics, Chief Technical Operations Officer Bryan Ball, highlighted the urgent necessity for compliant and cost-effective solutions. He stated, "Establishing a solid foundation for our quality and regulatory operations was crucial. Veeva Basics meets these needs by facilitating logical workflows alongside a templated library of standard operating procedures (SOPs) and forms necessary for effective training."
Furthermore, Bernhard Irlinger, Head of Quality at AiCuris, credited Veeva Basics for delivering a best-in-class solution coupled with global support for rapid staff upskilling. He emphasized Veeva’s dedication to innovation and customer success, making it the ideal partner for emerging biotech companies.
About Veeva Systems
Veeva Systems stands as a leader in providing cloud solutions tailored for life sciences, catering to both software and business consulting requirements across the industry. With over 1,500 clients, including the world's largest biopharmaceutical corporations and numerous emerging biotechs, Veeva is committed to fostering a balance among stakeholders while promoting product excellence and ongoing innovation. The company operates as a Public Benefit Corporation, aligning its mission with client success and industry growth. For detailed insights, stakeholders can visit the official Veeva website at veeva.com/eu.
Conclusion
The adoption of Veeva Basics by over 100 biotechs marks a transformative trend in the industry, highlighting the need for scalable, standardized operations in a rapidly changing ecosystem. With Veeva's ongoing commitment to innovation, these emerging companies are better positioned to meet future challenges as they develop new medicines for patients worldwide.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.